For anyone looking for a great starter technical analysis book. I’d recommend. I constantly read this over and over again. Started off keeping it beside me while watching live.
Never stop learning!
@JonnyRocketsOTC when you consider how they’ve been stacking patents and eliminating debt and Koos being 70+ it’s hard to imagine any other endgame for $RGBP
All imo of course
@Armando89271415 This may not be the last of the patent fillings. IMO, there may be more to come. But it matters of which ones may need to come out for finale of the potential buyout. No time table, I think it’s best not thinking of this when talking about investments.
$RGBP Breaking Out as Biotech Files Patent on Dendritic Cell Technologies to Augment Efficacy of Survivin mRNA Cancer Immunotherapeutic Vaccine
New Micro Cap Daily article 👇
https://t.co/Z0t4smQJa4
@indyfox500@BuggaTss We have immuno-oncology drug(s) ready for phase 1 clinical trials, which means.. soon we "should" expect funding in the form of either M&A/share purchasing/licensing deal(s)/collaboration deal, etc... nothing guarenteed, but the odds are heavily in favor. $RGBP $RGBPP
$RGBP $RGBPP MASSIVE PR
Putting Moderna $MRNA and Pfizer $PFE in PR!?
"To date there is no mRNA immunotherapy available for treating cancer. This patent application protects the use of our patented survivin mRNA both as a stand-alone vaccine and as an immunotherapy."